Aim: To evaluate the microleakage at the implant-abutment (I-A) interface of Morse tapered implants inoculated with different volumes of bacterial suspension. Methods: Morse tapered I-A sets were selected and divided in two groups depending on the type of abutment: passing screw (PS) and solid (S), and then subdivided into four subgroups (n=6) according to the suspension volume: PS1: 0.1 µL; PS3: 0.3 µL; PS5: 0.5 µL; PS7: 0.7 µL; S1: 0.1 µL; S3: 0.3 µL; S5: 0.5 µL and S7: 0.7 µL. A control test was performed to verify the presence of external contamination during the inoculation and the implants were incubated for microbiological analysis. The microleakage was evaluated every 24 h for 7 days by the clarity of solution. After this period, the implants were disassembled for confirmation of bacterial viability. Results: All the specimens with 0.7 µL and one sample of S5 presented turbidity in the control test indicating external contamination, and were excluded from the study. After 7 days of observation, none of the specimens presented positive results for microleakage and the bacterial viability was confirmed in all specimens. The 0.1 µL and 0.3 µL volumes did not present bacterial microleakage, meaning that these volumes may be inadequate for analysis. Conclusions: None of the sets evaluated showed bacterial microleakage at the I-A interface and the volume of 0.7 µL exceeded the internal capacity of the implants.
Introduction
Failures in implant therapy have been associated with lack of stability or misfit at the implant-abutment (I-A) interface 1 . Two-piece implants have a microgap depending on the interface type or system, but presence of fluid flow at this interface and its relationships are very variable [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . This has been correlated to the presence of bacterial infiltration and inflammatory cells that may lead to bone loss around this area 19 . Implant manufacturers try to reduce bacterial infiltration by increasing the accuracy and stability of the jointed pieces by fabricating very high precision mechanical parts 7 . Internal conical joints have greater mechanical stability of the I-A interface and have shown no crest bone loss [20] [21] . This has been explained by the stress distribution of the implant's long axis during function. The greater stability of the soft tissues provided by the tapered abutment design and its reduced diameter relative to the platform and absence of abutment micromobility by the self-locking feature reduces bacterial leakage at the interface or even prevents it [3] [4] [5] [6] [7] .
In vitro bacterial studies at the I-A interface of Morse taper implants have attempted to assess the actual advantage of mechanical locking of these joints, but variable results were found [2] [3] [4] [5] [6] [7] [8] 18 . These variations may be related to methodological bias in the tests such as: holding implants with forceps; hand inoculation of the bacterial suspension into the implants; using one single torquemeter for all samples; failure to measure the inner volume of the implant; using a higher amount of bacterial suspension than should be used; type of bacteria and its viability within the study conditions, and the sterile technique used when studying the inward flow from the outer part of the implant 15 . Different volumes of bacterial suspension for implants inoculation could minimize the variations found in the literature. Therefore, the objective of this study was to assess the microleakage at the I-A interface of Morse tapered implants with different abutments and to verify the influence of different volumes of bacterial suspension.
Material and methods
Forty-eight Morse taper implants (3.75 x 11.5 mm -NEODENT ® , Curitiba, PR, Brazil) and 24 passing screw abutment (PS) and solid abutments (S) (4.5x6x1.5 mm; 11.5º -Neodent ® , Curitiba, PR, Brazil) were selected and assigned to two groups according to the type of abutment (PS and S). The assemblies of both groups were further subdivided into four subgroups according to the amount of bacterial suspension inoculated into the inner part of the implants (n=6). PS1: 0.1 µL; PS3: 0.3 µL; PS5: 0.5 µL; PS7: 0.7 µL; S1: 0.1 µL; S3: 0.3 µL; S5: 0.5 µL and S7: 0.7 µL (Table 1) .
Escherichia coli strain ATCC 35218 was selected for bacterial microleakage evaluation because it is a facultative anaerobic bacterium, able to survive in adverse situations and has a good motility, and has been used in other in vitro tests 2, 5, 7, [13] [14] . This bacterium was cultivated in brain heart infusion broth -BHI (Biolife, Milano, Italy) for 24 h in an incubator at 37 °C (Biomatic, Porto Alegre, RS, Brazil). All the used instruments were autoclaved at 121 o C and 15 psi for 15 min. All the procedures and necessary materials were conducted under the clean conditions of a laminar flow hood (Veco, Campinas, SP, Brazil). A standard bacterial suspension dilution of 0.5 McFarland (10 8 colony forming unit/mL -CFU/mL) was used for minimizing the environmental adversity inside of the implants. The implants were set on a holder and an automatic pipette (0.1-20 µL, Labmate+ HT; PZ HTL S.A, Warsaw, Poland) was fixed to the vertical shaft of a prosthetic surveyor (BIOART, São Carlos, SP, Brazil.) 14 .
The pipette tip was inserted and loaded with the amount that was required for each experimental group.
After the inner part of the implant had been inoculated, the abutment was opened and carefully installed using sterile pliers. It was then tightened according to the manufacturer's recommendations by a manual torquemeter individually calibrated for each sample.
Control Test. Control Test. Control Test. Control Test. Control Test. All assemblies were immersed for 30 s in tubes containing sterile BHI broth until the I-A interface was completely coated. This test determined if there was any external contamination during the abutment installation and screw tightening process. The tubes of the control test were maintained in an incubator at 37 °C for up to 7 days in order to evaluate every 24 h the changes in the broth turbidity. A turbid broth indicated bacterial leakage during inoculation and/or abutment installation and that sample was excluded.
For negative control, the abutment was not connected to the implant and was not subjected to bacterial suspension and showed no turbidity. For positive control, the abutment was not connected to a fixture, but was subjected to the same bacterial culture as the groups and presented turbidity.
After the implants immersion in the control tubes, all the I-A samples were kept in microcentrifuge tubes (Eppendorf, Hamburg, Germany) with another sterile BHI broth until reaching the I-A interface coating. The I-A samples were also evaluated every 24 h by the same method of the control test. After 7 days, if no bacterial growth was observed, the I-A samples were opened in the laminar flow hood and the disassembled components were placed in a new tube with sterile BHI to assess the viability of the bacteria by turbidity. If the bacteria were not viable after this period, the sample would be excluded to prevent a false negative result.
Results
To validate the colonization and detection techniques, abutments similar to those in PS and S were kept disassembled and either exposed to bacterial culture or maintained sterile. Zero CFUs of E. coli were detected from sampling of abutments that were maintained sterile (negative control) ( Figure 1A ), whereas 10 McFarland (30 x 10 8 CFU/mL) of E. coli were detected in samples from abutments exposed to bacterial culture (positive control) ( Figure 1B) .
After the first 24 h of follow up one specimen of the control groups S5 and all the PS7 and S7 samples presented turbidity of the solution, which indicates bacterial contamination and they were excluded from the study. During the period of 7-day follow up, none of the other specimens presented positive results for bacterial microleakage (Table 2 ) ( Figure 1C ). The viability test using the disassembled components of I-A samples confirmed that E. coli survived inside the implants. Bacterial microleakage at the implant-abutment interface in Morse taper implants Table 2 . Table 2 . Table 2 . Table 2 . Table 2 . Results 
Discussion
All the specimens inoculated with 0.7 µL presented turbidity of the solution in the control test after the first 24 h, which indicated bacterial contamination. This showed that during the installation of the abutments, the volume of inoculation exceeded the internal capacity of the implants. Only one specimen of the S5 group presented positive results in the control test, but it may be due to problems in the experimental step rather than an inability to accommodate the volume in the inner parts of the implants. These results showed that for the studied system, the maximum volume is around 0.5 µL. Other studies evaluating Morse tapered systems used 0.1 µL to 0.5 µL of volume inoculation 2, [4] [5] 7 . However, only two studies reported the evaluation of the best inner volume for the studied system and used the same volume for different conical systems [4] [5] . The other studies did not find any difference among the internal volumes of the systems 2, 7 . The groups inoculated with 0.7 µL were excluded due to the positive results of the control test. For the other groups, after the period of 7-day follow up, none of the evaluated specimens showed positive results for bacterial microleakage at the I-A interface. These results corroborate studies under static conditions where Morse tapered implants showed reduced levels of bacterial flow in the I-A interface 4, [6] [7] , although there was no consensus [5] [6] . Alterations in the shape of the abutments may also have harmed the mechanical imbrication of the conical interfaces allowing greater bacterial flow in the interface 3, 6 , which was not observed in this study. The use of reduced volumes of bacterial suspension for inoculation, with high concentrations (superior to 1.5 x 10 8 CFU/mL) and longer periods of follow up, over 7 days, may create an extremely adverse environment for bacterial survival inside the implants, reducing significantly the possibility of microleakage, because of the bacterial competition. These volumes may also lead to low levels of bacterial suspension in relation to the I-A interface, hindering the microleakage 15 and showing negative results for microleakage as in previous studies 7, 16 . These results reinforce the theory that high concentrations of bacteria and reduced volumes may mask the microleakage [14] [15] . Moreover, it may lead to false negative results caused by bacterial death inside the implants. In order to avoid this, beyond the precautions on the concentration of bacterial suspension, bacterial viability was confirmed after the follow up period by disassembling the specimens that presented negative results for microleakage. Precaution involving the concentration of bacterial suspensions is already a reality; 4, 5, 14 but confirmation of bacterial viability was made only in two studies 5, 14 . The chosen post-inoculation control test was immersion of the implants up to the I-A interface coating for 30 s. The overflow control by immersion was used in a previous study and showed good results 9 . Currently, in vitro tests for microleakage with corpuscular bacteria showed no flow at the I-A interface, even in hexagonal joints, contradicting what was previously thought 9, 14 . Even though these findings may be different in situations of mechanical load, inner joints are more stable and could be more beneficial, but few studies compared this situation 3, 13 . Moreover, tests using dyes and bacterial toxins of molecular sizes, which are the real cause of marginal bone crest resorption, showed that microleakage occurs even in Morse tapered joints regarded as hermetically stable, and even in absence of load, its flow increases with time 8, 11 . Therefore, more studies are required using bacteria, dyes and bacterial toxins under load conditions. These studies will guide the understanding about the flow that occurs at this interface and its relation to the microgap. This may solve clinical problems related to this process, mainly during the first years in function.
The present study verified that despite the fact that tests for bacterial viability showed that the volumes of 0.1 and 0.3 µL allowed the survival of bacteria during the period of 7 days, it may be insufficient to evaluate the microleakage at the I-A interface, since it did not occupy the maximum capacity of the inner parts of the implant. The 0.5 µL volume showed that it could be used for in vitro tests using Morse tapered implants with different abutments (PS and S), without overflow of the volume after abutment installation. The need of determining and using the closest volume of the inner parts of the implants and controlling the bias related to the methodology should be underlined in order to avoid false positive or negative results.
Within the limitations of this study, it may be concluded that the volume of 0.7 exceeds the inner capacity and should not be used. None of the other evaluated specimens showed bacterial microleakage at the I-A interface. However, the volumes of 0.1 and 0.3 may be insufficient for future tests.
This suggests that the 0.5 µL volume seems to be closer to ideal for the studied groups.
